facebook  twitter  twitter  LinkedIn      

Products:


Breast-D™ - Research Citations

Calcium D-glucarate

A. K. Adams, M. Hanausek, U. Sherman, Z. Walaszek, "Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland", Cancer Letters 49(1), (1990), 51-57

Walaszek, Zbigniew, Malgorzata Hanausek-Walaszek, John P. Minton, and Thomas E. Webb, "Dietary glucarate as anti-promoter of 7, 12-dimethylbenz [a] anthracene-induced mammary tumorigenesis", Carcinogenesis 7(9), (1986), 1463-1466

DIM

B.B. Aggarwal, H. Ichikawa, “Molecular targets and anticancer potential of indole-3-carbinol and its derivatives”, Cell Cycle 4, (2005), 1201–15

D. Malejka-Giganti, D. R. Parkin,“Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol”, Cancer Detect Prev (2004), 28(1), 72-79

K.M. Dalessandri, G.L. Firestone, M.D. Fitch, H.L. Bradlow, L.F. Bjeldanes, “Pilot study: effect of 3,3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer”, Nutrition Cancer 50, (2004), 161–167

L. F. Bjeldanes, G. H. Chang, Y. C. Chang, G. Firestone, B. C. Peng, J. Riby, “Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol” Biochem.Pharmacol 58(5), (1999), 825-834

L F. Bjeldanes, G.L. Firestone, Y. Gong, H. Sohn, L. Xue, “3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells”,  Cancer Res 66(9), (2006), 4880-4887

Shilpi Rajoria, Robert Suriano, Andrea George, Arulkumaran Shanmugam, Stimson P. Schantz, Jan Geliebter, Raj K. Tiwari, “Estrogen Induced Metastitic Modulators MMP-2 and MMP-9 Are Targets of 3,3’ –Diindolylmethane in Thyroid Cancer”, PloS One 6(1), (2011), e15879

Green Tea

Naghma Khan, and Hasan Mukhtar, “Multitargeted Therapy of Cancer by Green Tea Polyphenols”, National Institutes of Health Cancer Letter 269(2), (2008), 269-280

I.F.Benzie, K.C. Han, and W.C. Wong, “Genoprotective effects of green tea (Camellia sinensis) in human subjects: results of a controlled supplementation trial”, Br J Nutr. 1, (2010), 1-8

Y. Higashi, K. Imai, K. Nakachi, K. Suemasu, K. Suga, and T. Takeo, “Influence of drinking green tea on breast cancer malignancy among Japanese patients”, Jpn J Cancer Res 89(3), (1998), 254-61

G.H. Guyatt, E.J. Mills, D. Seely, S. Verma, and P.Wu, “The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis”, Integr Cancer Ther. 4(2), (2005), 144-55

Vitamin D

Anne Boutten, Marie-Christine Boutron- Ruault, Francoise Clavel-Chapelon, Thierry Dupre, Pierre Engel, Guy Fagherazzi and Sylvie Mesrine, “ Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort”, American Association for Cancer ResearchCancer: Epidemiol Biomarkers Prev 19, (2010), 2341

C. Garland, F. Garland, "Serum 25-Hydroxyvitamin D and Colon Cancer: Eight-Year Prospective Study”, The Lancet 334(8673), (1989), 1176-1178

D. E. Cole, H. M. Trang, "Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2", Am J Clin Nutr 68(4), (1998), 854-858

G. Rammos, P. Tseke, "Vitamin D, the renin-angiotensin system, and insulin resistance", International Urology and Nephrology 40(2), (2008), 419-426

Heidi Barnett, Kristina M. Blackmore, Julia A. Knight, Maia Lesosky, Janet M. Raboud and Reinhold Vieth, “Vitamin D From Dietary Intake and Sunlight Exposure and the Risk of Hormone-Receptor-Defined Breast Cancer”, Am J Epidemiol 168, (2008), 915-924

H.L. Bradlow, L.F. Bjeldanes K.M. Dalessandri, G.L. Firestone and M.D. Fitch, “Pilot Study: effect pf 3, 3’-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer”, Nutr Cancer 50(2), (2004), 161-7

Hugo Van Baelen, Roger Bouillon, Marc De Maeyer, Anja Rabijns, Camiel De Ranter, Christel Verboven, “A structural basis for the unique binding features of the human vitamin D-binding protein”, Nature Structural Biology 9(2), (2002), 131-136

J. L. Anderson, H. T. May, "Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population", The American Journal of Cardiology 106(7), (2010), 963-968

J. Lau, A.G. Pittas, "The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis", Journal of Clinical Endocrinology & Metabolism 92(6), (2007), 2017-2029

K. Helzlsouer, J.Tangrea, "Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men”, Cancer Causes and Control 8(4), (1997), 615-625

L.A.G. Armas, J. Grote, R.P. Heaney, R.L. Horst, R.R. Recker, “Vitamin D3 is More Potent Than Vitamin D2 in Humans”, Journal of Clinical Endocrinology & Metabolism

Laura A.G. Armas, Bruce W. Hollis and Robert P. Heaney, “Vitamin D2 is much less effective than Vitamin D3 in Humans”, The Journal of Clinical Endocrinology and Metabolism 89(11), (2004), 5387-5391

Lisa A.Houghton, and Reinhold Vieth, "The case against ergocalciferol (vitamin D2) as a vitamin supplement", The American Journal of Clinical Nutrition 84(4), (2006), 694-697

M. F. Holick, “Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease", Am J Clin Nutr 80(6), (2004), 1678S-1688S

M. F. Holick, "Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis", Am J Clin Nutr 79(3), (2004), 362-371

Michael F. Holick, “The Vitamin D Epidemic and its Health Consequences”, J Nutr 135, (2005), 2739S-2748S

M. J. Pencina, T. J. Wang, “Vitamin D Deficiency and Risk of Cardiovascular Disease", Circulation 117(4), (2008), 503-511

Pam Harrison, “Vitamin D Insufficiency Linked to Aggressive Breast Tumors”, Medscape, (2011)

R. P. Heaney, R. R. Recker, "Vitamin D3 Is More Potent Than Vitamin D2 in Humans" Journal of Clinical Endocrinology & Metabolism 96(3), (2011), E447-E452

Robert P. Heaney, “Lessons for nutritional science from vitamin D”, Am J Clin Nutr 69, (1999), 825-6

Robert P. Heaney, “Vitamin D: Criteria for safety and efficacy”, Nutrition Reviews 66(2), (2008), S178-S181

Saijun Fan, Qinghui Meng, Eliot M. Rosen,  Tapas Saha, and Fazlul H. Sarkar “Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protects against oxidative stress in a BRCA1-dependent manner”, Cancer Res. 69(15), (2009), 6083-6091

S. Hatse, D. Lambrechts, “Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome and genetic determinants of vitamin D insufficiency", Carcinogenesis, (2012)

U. A. Ajani, E. S. Ford, "Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults", Diabetes Care 28(5), (2005), 1228-1230

Y. Liel, E. Ulmer, "Low circulating vitamin D in obesity", Calcif Tissue Int 43(4), (1988), 199-201


 

Pure Essence Labs - Home Page